First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m(2) Cisplatin for Locally Advanced Head and Neck Cancer

Many patients with squamous cell carcinoma of the head and neck (SCCHN) receive cisplatin-based chemoradiation. Cisplatin 100 mg/m(2) every three weeks is toxic and alternative cisplatin regimens are desired. Two courses of 20 mg/m(2)/day 1–5 (cumulative 200 mg/m(2)) were shown to be similarly effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwaan, Inga, Soror, Tamer, Idel, Christian, Pries, Ralph, Bruchhage, Karl L., Hakim, Samer G., Yu, Nathan Y., Rades, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300787/
https://www.ncbi.nlm.nih.gov/pubmed/37373994
http://dx.doi.org/10.3390/jpm13061006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300787/
https://www.ncbi.nlm.nih.gov/pubmed/37373994
http://dx.doi.org/10.3390/jpm13061006

Ejemplares similares